# Revvity Inc. (RVTY) Q2 2025 Financial Results Summary
Revvity, Inc. (NYSE: RVTY) released its financial results for the second quarter of 2025 on July 28, 2025.
## Financial Highlights
– **Revenue**:
– **Total**: $720 million, a **4% increase** compared to **$692 million** in Q2 2024.
– **Organic**: 3% growth versus the previous year.
– **Earnings per Share**:
– **GAAP EPS**: $0.46, up from **$0.45** in the same period last year.
– **Adjusted EPS from continuing operations**: $1.18, a decrease from **$1.22** in Q2 2024.
– **Operating Income**:
– **GAAP operating income** from continuing operations: $91 million, compared to **$86 million** in Q2 2024.
– **Adjusted operating income**: $192 million, down from **$199 million** year-over-year.
– **Operating Profit Margin**:
– **GAAP Operating Profit Margin**: 12.6%, slightly up from **12.4%** in the same quarter last year.
– **Adjusted Operating Profit Margin**: 26.6%, down from **28.8%** in Q2 2024.
## Segment Performance
### Life Sciences
– **Revenue**: $366 million, a **5% increase** from **$349 million** year-over-year.
– **Organic Revenue Growth**: 4% compared to last year.
– **Adjusted Operating Income**: $115 million, down from **$118 million** in Q2 2024.
– **Adjusted Operating Profit Margin**: 31.6%, decreased from **33.7%** in the same period last year.
### Diagnostics
– **Revenue**: $354 million, a **3% increase** from **$343 million** in Q2 2024.
– **Organic Revenue Growth**: 2%, as compared to last year.
– **Adjusted Operating Income**: $89 million, down from **$93 million** in Q2 2024.
– **Adjusted Operating Profit Margin**: 25.2%, lower than **27.0%** in Q2 2024.
## Guidance Updates
– **Full Year 2025 Revenue Guidance**: Updated to a range of **$2.84 to $2.88 billion**, with an estimate of **2% to 4% organic growth**.
– **Adjusted EPS Guidance**: Updated to a range of **$4.85 to $4.95**.
## Cash Flow Highlights
– **Net Income**: $53.9 million, slightly lower than **$55.4 million** in Q2 2024.
– **Cash, Cash Equivalents**: Totaled **$991.8 million** at the end of June 2025, down from **$1,163.4 million** at the end of December 2024.
## Shareholder Returns
– **Dividends**:
– A total of **$8.3 million** in dividends was declared, slightly down from **$8.6 million** in Q2 2024.
– **Repurchase**:
– The company repurchased **$293.9 million** in shares during the quarter.
## Additional Information
– Revvity’s financial results show a strong performance despite a slight decline in adjusted profitability and margins. The company remains confident about its future, bolstered by a robust pipeline of innovation and operational discipline.
– The performance review emphasizes commitment to delivering long-term value to shareholders while navigating the evolving market conditions.
—
This financial summary encapsulates the key figures from Revvity Inc.’s Q2 2025 report, demonstrating both strong growth metrics and some challenges relative to profitability.
| Three Months Ended | Six Months Ended | |||
|---|---|---|---|---|
| June 29, 2025 | June 30, 2024 | June 29, 2025 | June 30, 2024 | |
| Revenue | $720,284 | $691,685 | $1,385,046 | $1,341,605 |
| Cost of revenue | 327,728 | 306,179 | 616,944 | 601,052 |
| Selling, general and administrative expenses | 248,526 | 251,650 | 498,245 | 512,221 |
| Research and development expenses | 53,270 | 48,132 | 106,867 | 98,492 |
| Operating income from continuing operations | 90,760 | 85,724 | 162,990 | 129,840 |
| Interest income | -8,345 | -20,512 | -18,426 | -40,598 |
| Interest expense | 22,937 | 24,717 | 45,901 | 49,114 |
| Change in fair value of investments | 1,955 | -7,777 | -1,118 | -6,971 |
| Other expense, net | 5,563 | 2,634 | 15,601 | 7,084 |
| Income from continuing operations, before income taxes | 68,650 | 86,662 | 121,032 | 121,211 |
| Provision for income taxes | 13,428 | 14,056 | 24,141 | 19,909 |
| Income from continuing operations | 55,222 | 72,606 | 96,891 | 101,302 |
| Loss from discontinued operations | -1,274 | -17,246 | -706 | -19,929 |
| Net income | 53,948 | 55,360 | 96,185 | 81,373 |
| Diluted earnings per share: Income from continuing operations | 0.47 | 0.59 | 0.82 | 0.82 |
| Loss from discontinued operations | -0.01 | -0.14 | -0.01 | -0.16 |
| Net income | 0.46 | 0.45 | 0.81 | 0.66 |
| Weighted average diluted shares of common stock outstanding | 117,538 | 123,477 | 118,882 | 123,494 |
| June 29, 2025 | December 29, 2024 | |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | 991,849 | 1,163,396 |
| Accounts receivable, net | 661,138 | 632,400 |
| Inventories, net | 388,467 | 367,587 |
| Other current assets | 194,729 | 186,225 |
| Total current assets | 2,236,183 | 2,349,608 |
| Property, plant and equipment, net | 499,026 | 482,217 |
| Operating lease right-of-use assets, net | 177,168 | 167,716 |
| Intangible assets, net | 2,514,368 | 2,640,921 |
| Goodwill | 6,614,989 | 6,463,619 |
| Other assets, net | 321,055 | 288,397 |
| Total assets | 12,362,789 | 12,392,478 |
| Current liabilities: | ||
| Current portion of long-term debt | 230 | 242 |
| Accounts payable | 178,151 | 167,463 |
| Accrued expenses and other current liabilities | 493,433 | 485,395 |
| Total current liabilities | 671,814 | 653,100 |
| Long-term debt | 3,214,324 | 3,150,476 |
| Long-term liabilities | 760,178 | 770,523 |
| Operating lease liabilities | 160,305 | 151,505 |
| Total liabilities | 4,806,621 | 4,725,604 |
| Total stockholders’ equity | 7,556,168 | 7,666,874 |
| Total liabilities and stockholders’ equity | 12,362,789 | 12,392,478 |
